What's New With Flu Shots

CSL Seqirus today announced new data will be presented at the European Scientific Working Group on Influenza Conference taking place from 17-20 September 2023 in Spain.

Data from various studies, including real-world evidence, economic and cost-effectiveness modeling, and clinical studies across seasonal and pandemic influenza, will be shared as posters and oral presentations.

"At CSL Seqirus, public health protection is at our core and is what drives us to safeguard at-risk communities against seasonal and pandemic influenza threats," said Raja Rajaram, M.D., Head of Global Medical Strategy, CSL Seqirus, in a press release on September 15, 2023.

"Delivering on our promise means continually gathering and analyzing data to assess the value and impact of our vaccines, and we look forward to sharing results from many of these studies at ESWI that emphasize the national, regional, and global impact."

Influenza is a contagious seasonal respiratory disease that may cause severe illness and life-threatening complications in some people.

On September 4, 2023, the World Health Organization published Influenza Update N° 453, indicating that influenza detections remained low globally, with activity in many Southern Hemisphere and Oceania countries.

As of September 15, 2023, the new flu and Respiratory Syncytial Virus seasons have begun to impact people in the United States.

An updated overview of influenza vaccines targeting the 2023-2024 flu viruses is posted at Precision Vaccinations.